Literature DB >> 132144

Diminished mixed lymphocyte reaction in ankylosing spondylitis, relatives, and normal individuals all with HL-A 27.

B Nikbin, D A Brewerton, D C James, J R Hobbs.   

Abstract

The mixed lymphocyte reaction against a pool of blocked lymphocytes was studied in individuals with and without HL-A 27, including controls, spouses, parents, sibs, and offspring, and patients with ankylosing spondylitis. In controls without HL-A 27 the mean increment of counts perminute was 46,630 compared with 29,860 in asymptomatic controls and relatives with HL-A 27 and 26,277 in spondylitic patients with HL-A 27. The mean response was also reduced to 34,902 in sibs and offspring without HL-A 27, and to 20,916 in three patients with spondylitis in the absence of HL-A 27.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 132144      PMCID: PMC1006504          DOI: 10.1136/ard.35.1.37

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  2 in total

1.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

2.  HL-A, immune-response genes, and disease.

Authors:  H O McDevitt; W F Bodmer
Journal:  Lancet       Date:  1974-06-22       Impact factor: 79.321

  2 in total
  8 in total

Review 1.  Immune functions and inflammatory reactions in HLA-B27 positive subjects.

Authors:  R Tertti; P Toivanen
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

2.  Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.

Authors:  R Bucknall; M Leirisalo-Repo; O Laitinen; J V Jones
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

3.  Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27.

Authors:  C T Pease; J N Fordham; H L Currey
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

4.  Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27.

Authors:  F T Christiansen; B R Hawkins; R L Dawkins
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

5.  Progressive ankylosis (ank/ank) in mice: an animal model of spondyloarthropathy. III. Proliferative spleen cell response to T cell mitogens.

Authors:  H E Krug; M L Mahowald; C Clark
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

Review 6.  Cytokines and the immunopathology of the spondyloarthropathies.

Authors:  J Braun; J Sieper
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

7.  T lymphocytes in ankylosing spondylitis and the influence of sulphasalazine treatment.

Authors:  N Feltelius; R Hällgren; O Sjöberg
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

8.  Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis.

Authors:  R Leino; R Vuento; S Koskimies; M Viander; A Toivanen
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.